Integration of knowledge and biobank resources in comprehensive translational approach for personalized prevention and treatment of metabolic disorders (H2020 project)

INTEGROMED is aiming to provide LBMC with the opportunity to integrate the experience of research excellence institutions and existing resources by creating a research and innovation network with three internationally leading organizations in the translational medicine area – University of Dundee, Lund University, and Weizmann Institute of Science. The strategy of INTEGROMED is to increase excellence and develop sustainable approach targeting virtually all aspects of translational medicine including the optimal use of clinical and biobank resources, integration of different omics in systemic workflow, reaching development of bedside applications and fostering entrepreneurism. Project has a strong focus on study of metabolic disorders including type 2 diabetes, however the training, mentoring and stuff exchange activities as well as practical outcomes will be available for other fields including researchers, clinicians and other stakeholders in Latvia, promoting the implementation of the developed strategies at larger scale. The result of project will be accomplished by following three main objectives. (1) To improve and optimize the use of resources provided by large biobanks and prospective cohorts in combination with national health care system, improve knowledge in establishment of clinical studies for development of precision medicine approaches. (2) To strengthen collaboration-based training of specialists in areas of multi-omics approaches, bioinformatics, and modelling to increase excellence in implementing cutting edge multi omics technologies in such areas as genomics, methylation and expression profile, microbiome and metabolome analysis. (3) To elaborate a long-term strategy and sustainability plan involving all relevant stakeholders, ensure development and training in clinical applications and entrepreneurial skills to build an innovation ecosystem around LBMC.

Read more…

This November (8-10 November, 2021) I had an opportunity to take part in the Europe Biobank Week 2021 with this year’s theme “Biobanking for our Future – Opportunities Unlocked”, where I was honored to be represented in two posters as part of the Latvian Biomedical Research & Study centre team, where I work as an IT-expert. (read more…)

Recently I have delivered an Invited Talk at the International Conference and Expo on Nanotechnology and Nanomaterials 2021: “Open Data as a driver of Society 5.0: how you and your scientific outputs can contribute to the development of the Super Smart Society and transformation into Smart Living?“ (read more…)

This October we have successfully prepared and submitted the next INTEGROMED deliverable “Guidelines for the maintenance of efficient biobank, health register and research associated data management”. It aimed at improving awareness among all stakeholders within LBMC and outside it about the data ecosystem. We have inspected the current situation, identified weak aspects, defined the room for improvement and planned activities to be carried out. This set of guidelines should create a baseline for other (bio)medical organizations and be consistent with the cooperation-oriented biobank paradigm (read more…)

INTEGROMED is funded by the European Union under the Horizon 2020 programme, grant agreement 857572.